Clinuvel Pharmaceuticals Limited (CLVLY) To Go Ex-Dividend on September 9th

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) announced a dividend on Friday, August 30th, NASDAQ reports. Investors of record on Monday, September 9th will be paid a dividend of 0.0299 per share on Monday, September 30th. The ex-dividend date of this dividend is Monday, September 9th. This is a positive change from Clinuvel Pharmaceuticals’s previous dividend of $0.03.

Clinuvel Pharmaceuticals Stock Performance

Shares of OTCMKTS CLVLY opened at $9.43 on Friday. The company has a 50 day simple moving average of $9.74 and a 200-day simple moving average of $9.75. Clinuvel Pharmaceuticals has a 1 year low of $8.42 and a 1 year high of $12.06.

Clinuvel Pharmaceuticals Company Profile

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).